Key result
Group 1, Group 4, or advanced PH requires specialized RV-targeted treatments and transfer to expert centers.
Why the study?
Pulmonary hypertension is increasingly common in intensive care unit admissions, requiring proper assessment and specific management strategies that deviate from standard intensive care.
This review outlines the critical care management, diagnosis, and specialized treatment of patients with pulmonary hypertension in the ICU.
Prompts early expert center transfer for specialized RV care; extends evidence synthesis to ICU management of pulmonary hypertension.
Pulmonary hypertension, defined as an elevation of the mean pulmonary artery pressure above 20 mm Hg, is an increasingly common diagnosis in patients admitted to the intensive care unit either as a primary pathology or as the result of other medical conditions. Proper assessment to identify the contributing factors and identify key specific etiologies is essential to properly manage these patients and improve patient outcomes. A subset of patients with causes of pulmonary hypertension such as Group 1 pulmonary arterial hypertension or Group 4 chronic thromboembolic pulmonary hypertension require specific treatments that deviate from usual intensive unit care and are critical to patients’ survival. These patients and patients with advanced pulmonary hypertension from other causes may benefit from specialized treatments targeting the right ventricle and pulmonary circulation complex, and warrant transfer to a center with pulmonary hypertension expertise. This review will discuss pulmonary hypertension epidemiology, physiology of the right ventricle and pulmonary circulation complex, stepwise diagnosis and classification of patients, management of cardiorespiratory support medications and devices, perioperative considerations, and special populations such as transplant candidates and pregnancy.
No takes yet. Share an insight, caveat, or question.
Deschamps et al. (2026) studied this question. Patients with Group 1, Group 4, or advanced pulmonary hypertension require specialized right ventricle-targeted treatments and warrant transfer to expert centers for critical care management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: